AltMountain

AVSF - Beacon Biosignals 2026, LLC

Boston, MA · CIK 2141770
Emerging

AVSF - Beacon Biosignals 2026, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Oct 13, 2026, it has sold $893,500 of interests to 59 investors since its first sale in Sep 2026. The minimum investment it accepts from an outside investor is $5,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Michael Collins.

Total raised
$893,500Cumulative sales reported on Form D
Investors
59
First sale
Sep 18, 2026
Minimum investment
$5,000
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Michael Collins
Latest Form D
Oct 13, 2026

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌‌⁠

Questions about AVSF - Beacon Biosignals 2026, LLC

What is the minimum investment for AVSF - Beacon Biosignals 2026, LLC?

According to its latest Form D, filed Oct 13, 2026, the minimum investment AVSF - Beacon Biosignals 2026, LLC accepts from an outside investor is $5,000.

Who can invest in AVSF - Beacon Biosignals 2026, LLC?

AVSF - Beacon Biosignals 2026, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has AVSF - Beacon Biosignals 2026, LLC raised?

AVSF - Beacon Biosignals 2026, LLC reports $893,500 sold from 59 investors on its Form D filed Oct 13, 2026. This is cumulative sales since the offering began, not current assets or performance.

Where is AVSF - Beacon Biosignals 2026, LLC based?

AVSF - Beacon Biosignals 2026, LLC is based in Boston, Massachusetts.

When did AVSF - Beacon Biosignals 2026, LLC launch?

AVSF - Beacon Biosignals 2026, LLC reports its first sale in Sep 2026, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).

Size compared with every venture capital fund

Raised more than 62% of the 533 venture capital funds based in Massachusetts, and more than 58% of all 14,901 that report sales.

More venture capital funds in Boston

Similar-size venture capital funds in Massachusetts

All venture capital funds in Massachusetts